Literature DB >> 21207521

The action sites of propofol in the normal human brain revealed by functional magnetic resonance imaging.

Hui Zhang1, Wei Wang, Zhijing Zhao, Yali Ge, Jinsong Zhang, Daihua Yu, Wei Chai, Shengxi Wu, Lixian Xu.   

Abstract

Propofol has been used for many years but its functional target in the intact brain remains unclear. In the present study, we used functional magnetic resonance imaging to demonstrate blood oxygen level dependence signal changes in the normal human brain during propofol anesthesia and explored the possible action targets of propofol. Ten healthy subjects were enrolled in two experimental sessions. In session 1, the Observer's Assessment of Alertness/Sedation Scale was performed to evaluate asleep to awake/alert status. In session 2, images with blood oxygen level dependence contrast were obtained with echo-planar imaging on a 1.5-T Philips Gyroscan Magnetic Resonance System and analyzed. In both sessions, subjects were intravenously administered with saline (for 3 min) and then propofol (for 1.5 min) and saline again (for 10.5 min) with a constant speed infusion pump. Observer's Assessment of Alertness/Sedation Scale scoring showed that the subjects experienced conscious–sedative–unconscious–analepsia, which correlated well with the signal decreases in the anesthesia states. Propofol induced significant signal decreases in hypothalamus (18.2%±3.6%), frontal lobe (68.5%±11.2%), and temporal lobe (34.7%±6.1%). Additionally, the signals at these three sites were fulminant and changed synchronously. While in the thalamus, the signal decrease was observed in 5 of 10 of the subjects and the magnitude of decrease was 3.9%±1.6%. These results suggest that there is most significant inhibition in hypothalamus, frontal lobe, and temporal in propofol anesthesia and moderate inhibition in thalamus. These brain regions might be the targets of propofol anesthesia in human brain.
© 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21207521     DOI: 10.1002/ar.21069

Source DB:  PubMed          Journal:  Anat Rec (Hoboken)        ISSN: 1932-8486            Impact factor:   2.064


  6 in total

1.  Alkylphenol inverse agonists of HCN1 gating: H-bond propensity, ring saturation and adduct geometry differentially determine efficacy and potency.

Authors:  Rebecca L Joyce; Nicole P Beyer; Georgia Vasilopoulos; Kellie A Woll; Adam C Hall; Roderic G Eckenhoff; Dipti N Barman; J David Warren; Gareth R Tibbs; Peter A Goldstein
Journal:  Biochem Pharmacol       Date:  2019-02-13       Impact factor: 5.858

Review 2.  Anesthetic effects of propofol in the healthy human brain: functional imaging evidence.

Authors:  Xiao-xing Song; Bu-wei Yu
Journal:  J Anesth       Date:  2014-07-24       Impact factor: 2.078

3.  Resting-State fMRI Networks in Children with Tuberous Sclerosis Complex.

Authors:  Banu Ahtam; Mathieu Dehaes; Danielle D Sliva; Jurriaan M Peters; Darcy A Krueger; Elizabeth Martina Bebin; Hope Northrup; Joyce Y Wu; Simon K Warfield; Mustafa Sahin; Patricia Ellen Grant
Journal:  J Neuroimaging       Date:  2019-07-14       Impact factor: 2.486

Review 4.  No cognitive processing in the unconscious, anesthetic-like, state of sleep.

Authors:  Robert P Vertes; Stephanie B Linley
Journal:  J Comp Neurol       Date:  2020-06-30       Impact factor: 3.028

5.  Brain measures of nociception using near-infrared spectroscopy in patients undergoing routine screening colonoscopy.

Authors:  Lino Becerra; Christopher M Aasted; David A Boas; Edward George; Meryem A Yücel; Barry D Kussman; Peter Kelsey; David Borsook
Journal:  Pain       Date:  2016-04       Impact factor: 7.926

6.  Changes in effective connectivity by propofol sedation.

Authors:  Francisco Gómez; Christophe Phillips; Andrea Soddu; Melanie Boly; Pierre Boveroux; Audrey Vanhaudenhuyse; Marie-Aurélie Bruno; Olivia Gosseries; Vincent Bonhomme; Steven Laureys; Quentin Noirhomme
Journal:  PLoS One       Date:  2013-08-19       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.